These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3150239)
1. Effector mechanisms against neuroblastoma cells and their modulation by lymphokines. Iwami T; Yamashita U; Nakamura H; Yamagishi M Acta Paediatr Jpn; 1988 Aug; 30(4):483-91. PubMed ID: 3150239 [No Abstract] [Full Text] [Related]
2. [Role of lymphokines in the generation of cytotoxic T lymphocytes]. Kasakura S Rinsho Ketsueki; 1984 Apr; 25(4):479-87. PubMed ID: 6236311 [No Abstract] [Full Text] [Related]
3. Cytotoxic lymphocytes in human intestinal mucosa. Shanahan F; Brogan M; Nayersina R; Targan S Adv Exp Med Biol; 1987; 216A():457-63. PubMed ID: 3500580 [No Abstract] [Full Text] [Related]
4. Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity. Hiserodt JC; Chambers WH Ann N Y Acad Sci; 1988; 532():395-404. PubMed ID: 3052213 [No Abstract] [Full Text] [Related]
5. Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes. Main EK; Lampson LA; Hart MK; Kornbluth J; Wilson DB J Immunol; 1985 Jul; 135(1):242-6. PubMed ID: 3158702 [TBL] [Abstract][Full Text] [Related]
6. The influence of natural killer cells in neuroblastoma. Reynolds JV; Shou J; Choi H; Sigal R; Ziegler MM; Daly JM Arch Surg; 1989 Feb; 124(2):235-9. PubMed ID: 2492800 [TBL] [Abstract][Full Text] [Related]
7. Selective growth of natural cytotoxic but not natural killer effector cells in interleukin-3. Djeu JY; Lanza E; Pastore S; Hapel AJ Nature; 1983 Dec 22-1984 Jan 4; 306(5945):788-91. PubMed ID: 6197655 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of human neuroblastoma cell lines to cytotoxic T lymphocyte-mediated lysis. Zier KS; Pierson GR; Brown V J Neuroimmunol; 1990 Jul; 28(2):153-60. PubMed ID: 2362016 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of immune evasion of human neuroblastoma. Raffaghello L; Prigione I; Airoldi I; Camoriano M; Morandi F; Bocca P; Gambini C; Ferrone S; Pistoia V Cancer Lett; 2005 Oct; 228(1-2):155-61. PubMed ID: 15923080 [TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killer cytotoxicity in neonatal mononuclear cells: in vitro responses to tumor cell lines from pediatric solid tumors. Chin T; Toy C; Vandeven C; Cairo MS Pediatr Res; 1989 Feb; 25(2):156-60. PubMed ID: 2537488 [TBL] [Abstract][Full Text] [Related]
14. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174 [TBL] [Abstract][Full Text] [Related]
15. Natural killer and other effector cells. Stutman O; Lattime EC Symp Fundam Cancer Res; 1986; 38():221-58. PubMed ID: 3489260 [No Abstract] [Full Text] [Related]
16. [Natural cytotoxic cells (NK cells)]. Frydecka I Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1343-5. PubMed ID: 6371740 [No Abstract] [Full Text] [Related]
17. A lymphokine that activates the cytolytic program of both cytotoxic T lymphocyte and natural killer clones. Milanese C; Siliciano RF; Schmidt RE; Ritz J; Richardson NE; Reinherz EL J Exp Med; 1986 Jun; 163(6):1583-8. PubMed ID: 3519831 [TBL] [Abstract][Full Text] [Related]
18. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells. Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365 [TBL] [Abstract][Full Text] [Related]
19. [Cytotoxic cells of the NK type - their characteristics and role in anti-neoplastic immunity]. Janiak M; Lipski S Postepy Hig Med Dosw; 1982; 36(1-3):95-131. PubMed ID: 6763997 [No Abstract] [Full Text] [Related]
20. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells. Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]